Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-043026

aTYR PHARMA INC · LIFE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
May 12, 2015
Accepted (ET)
May 14, 2015 · 9:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3May 12, 2015C31,181—A31,181ISee Footnote
Common StockF1,F2,F4May 12, 2015C470,020—A600,015ISee Footnote
Common StockF5,F6,F4May 12, 2015C46,152—A646,167ISee Footnote
Common Stockholding———12,572D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series D Redeemable Convertible Preferred StockF3,F1,F2—May 12, 2015C248,024D——Common Stock31,1810I
Series A Redeemable Convertible Preferred StockF4,F1,F2—May 12, 2015C525,000D——Common Stock66,0040I
Series B Redeemable Convertible Preferred StockF4,F1,F2—May 12, 2015C1,200,000D——Common Stock150,8650I
Series B-2 Redeemable Convertible Preferred StockF4,F1,F2—May 12, 2015C1,440,058D——Common Stock181,0460I
Series C Redeemable Convertible Preferred StockF4,F1,F2—May 12, 2015C558,508D——Common Stock70,2160I
Series D Redeemable Convertible Preferred StockF4,F1,F2—May 12, 2015C15,031D——Common Stock1,8890I
Series E Redeemable Convertible Preferred StockF4,F3,F5,F6—May 12, 2015C446,827D——Common Stock46,1520I

Explanation of responses